Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Sponsors Are Not Liable Under State Law For Declining Patent Dance

Dec 15 2017

• By Brenda Sandburg

Court of Appeals for Federal Circuit Lafayette Park Across from White House Washington DC

Related Content

US Supreme Court Permits Earlier Biosimilar Launches; Penalty For Declining Patent Dance Uncertain

Jun 13 2017

Pfizer's Infliximab Biosimilar Approved In US But Won't Launch Against Inflectra

Dec 14 2017

Sandoz <em>Zarxio</em> Launch Still Faces Hurdles; ‘Chess Game’ With Amgen Continues

Jul 27 2015

Related Companies

Amgen, Inc.

Novartis AG

Johnson & Johnson

Pfizer Inc.

Celltrion, Inc.

Samsung Bioepis Co., Ltd.

Merck & Co., Inc.

Additional Topics

United States Policy Biosimilars Legal Issues Intellectual Property BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window